The Effect of Plasma Osmolality on Brain Glutamate
Conditions
Schizophrenia
What is the purpose of this trial?
This study is designed to test the hypothesis that plasma osmolality is linked with cortical glutamate concentrations in the brain. It also investigates whether the glutamate response in schizophrenia is enhanced compared to healthy controls.
Participation Guidelines
- Age:
- 21 Years - 45 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Yale University
- Dates:
- March 2007
- Last Updated:
- August 23, 2012
- Study HIC#:
- 0612002149
Clinicaltrials.gov ID: NCT00611741
For more information about this trial, contact:
Suravi Sircar
203-932-5711 ext 2224
suravi.sircar@yale.edu
Investigator
Handan Gunduz-Bruce, MD
Principal Investigator
